Amanda McDowell

National Kidney Month: What to know about IgA nephropathy

Each year in March, the National Institute of Diabetes and Digestive and Kidney Diseases puts on National Kidney Month, a month dedicated to raising awareness about kidney health and conditions. Chronic kidney disease, a grouping of conditions that damage the kidneys, impacts around 37 million Americans, and millions of others are considered to be at an increased risk.

Continue reading

An overview of key hemophilia facts

The rare, inherited blood disorder hemophilia is estimated to impact approximately 20,000 individuals in the United States, and over 400,000 worldwide. Currently, there is no cure for hemophilia — but through ongoing research, medical experts are continually learning more about the disease.

Continue reading

Antidote’s learnings from over 1,900 depression patients [whitepaper]

Depression, also known as clinical depression, Major Depressive Disorder, or MDD, is estimated to impact one out of six adults at some point in their lifetime, making it one of the most common mental disorders in the United States. It is estimated that the cost of depression totals $100 billion annually. While there are treatments available, finding the optimal one can place a significant burden ...

Continue reading

Understanding viral load and hepatitis B infections

Hepatitis B, sometimes abbreviated to HBV, is a liver infection that is one of the most serious in the world. If left untreated, hepatitis B can cause fibrosis, cirrhosis, hepatocellular carcinoma, and end-stage liver disease.

Continue reading

Why clinical trial matching software should put patients first

Before any new medication, therapy, or treatment is put onto the market, it must first be approved by the Food and Drug Administration. Part of this approval process is thorough testing through clinical trials to ensure that any therapy is safe and effective before it is released to the general public.

Continue reading

What are the stages of idiopathic pulmonary fibrosis?

Idiopathic pulmonary fibrosis, or IPF, can be a frightening diagnosis. IPF is a rare, progressive lung disease that develops differently for everyone, and managing its development can be difficult. However, some individuals are able to live with the disease and stay active for many years.

Continue reading

Small cell vs. non-small cell lung cancer: An overview

Lung cancer, the leading cause of cancer deaths in the United States, occurs when cells within the lung begin growing in an uncontrolled way, forming tumors or lesions. It typically begins in the cells lining the bronchi, and can eventually spread throughout the lung and to other parts of the body.

Continue reading

Understanding Parkinson’s disease through Antidote’s database insights [whitepaper]

Parkinson’s disease, a neurodegenerative brain disorder, impacts 10 million people across the world. Most commonly associated with tremors or shaking, it is a condition that significantly affects a person’s quality of life, and as of now, has no known cause. Individuals diagnosed with Parkinson’s are empowered to focus primarily on symptom management, which is typically done through medication ...

Continue reading

How Antidote recruits for rare disease trials

Rare Disease Day occurs every year on the last day of February, and is aimed at raising awareness and creating change for the 300 million individuals across the globe living with a rare disease. In the United States, a rare disease is defined as a condition that impacts less than 200,000 people — by that definition, about 1 in 10 individuals (roughly 30 million people) in America have a rare ...

Continue reading

How to find and take part in paid clinical trials

Participating in a clinical trial has many benefits, including working with condition specialists, getting access to personalized medical care, and helping science move forward — but did you know that some clinical trials offer compensation, as well?

Continue reading

Get our latest posts in your inbox